Work with thought leaders and academic experts in Immunology and Allergy

Companies can benefit from working with Immunology and Allergy experts in several ways. These experts can provide valuable insights and knowledge to enhance research and development efforts. They can help in the development of innovative solutions and treatments for allergies and immune-related disorders. Collaborating with these experts can also lead to the discovery of new diagnostic tools and technologies. Additionally, companies can gain a competitive edge by leveraging the expertise of Immunology and Allergy researchers to stay ahead in the market.

Researchers on NotedSource with backgrounds in Immunology and Allergy include Regan Hamel, Elvira Forte, Aayudh Das, Ph.D., Shariq Usmani, PhD, Dr. David Siderovski, Ph.D., Garrett A. Perchetti, Research Scientist - Virology, Mohammad Imran Khan, Dr. Justin Whalley, Ph.D, Rosani Matoso Silva, Ph.D., Lindsay Webb, PhD, Jeffrey Townsend, and Jo Boaler.

Elvira Forte

New York, New York, United States of America
15 Years Experience
Scientific strategist • Senior Scientist • Senior Scientific Editor
Education

Sapienza University of Rome

PhD, Pasteurian Sciences / January, 2011

Rome

Sapienza University of Rome

Master, Medical, Molecular and Cellular Biotechnology / October, 2006

Rome

Sapienza University of Rome

Bachelor, Biotechnology / October, 2004

Rome
Experience

Springer Nature

Associate/Senior Editor / June, 2021February, 2024

Helped shape and launch a new journal, Nature Cardiovascular Research, which publishes exceptional advances in the fields of cardiac, vascular, and blood biology, covering fundamental, translational, clinical, and public health research. • Assessed the novelty and impact of manuscripts within all the topics covered by the journal and chaperoned the whole revision process until acceptance for over 40% of all the content published by the journal since its start, with optimal processing times and excellent feedback from the authors. • Interfaced with scientists around the World, provided scientific guidance on how to improve manuscripts, or recommended more appropriate journals to publish with. Commissioned Comments, Reviews, News and Views on current topics, and summarized novel scientific findings in meaningful snippets and Research Highlights. • Contributed to the training and supervision of 2 Associate Editors; covered the Chief Editor's functions when needed.

Research Fellow/Associate Research Scientist / January, 2017June, 2021

• Analyzed the dynamic cellular changes during the fibrotic repair post-myocardial infarction, using cutting-edge techniques such as single-cell RNAseq with 10xChromium. Learned how to perform myocardial infarction in mice and assess the cardiac function via echography; analyze scRNAseq data using the Seurat package on R studio. • Completed a project aimed to characterize similarities and differences among fibroblasts from different organs cultured in the same conditions. Through cytometric, transcriptomic analysis, functional assays, shRNA and CRISPR-Cas9-mediated in vitro gene knockdowns we showed that fibroblasts isolated from different organs retain the expression of key transcription factors reflecting their embryological origin. • Collaborated with other laboratories in the Institute to design new mice models that could possibly recapitulate the symptoms of COVID-19; to analyze the response of mice with diverse genetic backgrounds to stressors.

Post-doctoral fellow/ Co-joint lecturer / May, 2013November, 2016

Developed projects aimed at understanding the embryological origin and function of a population of putative progenitor cells, cardiac colony forming unit fibroblasts cCFU-F, identified 2 years before in the lab (PMID: 22136928). • Performed cell lineage tracing and designed in vitro and in vivo cellular assays to assess the functional and immunomodulatory properties of PDGFRa+ fibroblasts in homeostasis and post-myocardial infarction with or without treatment with the PDGF-AB ligands. The data, presented in 3 international conferences and included in a preprint manuscript, have supported the use of a short-term treatment with PDGF-AB in a preclinical model of acute myocardial infarction in pigs. • Co-supervised 2 Ph.D. students at University of New South Wales

Scientific Editor / March, 2024Present

Consultant freelancer position within a team of former journal editors and grants specialists • Helped scientists increase the impact of their science by providing advice, in-depth editing, and feedback on manuscripts.

Most Relevant Research Expertise
Immunology and Allergy
Other Research Expertise (27)
fibrosis
inflammation
cardiomyopathies
Physiology
Cardiology and Cardiovascular Medicine
And 22 more
About
Motivated and growth-driven biomedical scientist with over 15 years of experience in the cardiovascular field. Strong background in cell and molecular biology, data analysis, and interpretation. Seeking #newopportunities to deliver value as a Senior Scientist, Associate Principal Scientist, Scientific Liaison, or Scientific Consultant within a company that combines new technologies such as single-cell omics and AI for drug discovery and personalized medicine. <br> Throughout my career, I've used various in vivo and in vitro models to investigate the molecular and cellular mechanisms of fibrosis and inflammation in the heart, and how these mechanisms are affected in mice with different genetic backgrounds. My experience includes project management and mentoring. I completed three projects involving international collaborations, supervised two junior researchers, and taught cellular and molecular techniques to at least six professionals. As one of the launching editors and senior editor at Nature Cardiovascular Research, I oversaw the quality of the content published in the journal and the editorial process. I collaborated with authors, reviewers, and editors to ensure the highest standards of scientific rigor, relevance, and innovation. I also contributed to the journal's vision, strategy, and outreach, promoting the latest advances and discoveries in the cardiovascular and hematology fields. This experience has sharpened my analytical and communication skills and broadened my understanding of the field, covering a wide range of studies, from basic research to clinical, epidemiological, and public health research. My mission is to advance the knowledge and practice of cardiovascular medicine and to bridge the gap between research and clinical applications. Keywords: cardiovascular, #fibrosis, inflammation, cardioimmunology, RNA, single-cell biology, #transcriptomics, imaging, animal models, small animal surgery, and scientific writing.

See Full Profile

Aayudh Das, Ph.D.

Boston, Massachusetts, United States of America
10 Years Experience
Scientist at Garuda therapeutics, specialized in Genomics and Computational Biology
Education

University of Vermont

PhD, Plant Biology / April, 2022

Burlington, Vermont, United States of America

Texas A&M University

Master's in Biochemistry, Biochemistry & Biophysics / May, 2016

College Station, Texas, United States of America

University of Calcutta

Master's, Biotechnology

Kolkata
Experience

Garuda therapeutics

Scientist / July, 2023Present

The Pennsylvania State University - University Park Campus

Postdoctoral Researcher / June, 2022July, 2023

University of Vermont

Research Assistant / May, 2016May, 2022

Most Relevant Research Expertise
Immunology and Allergy
Other Research Expertise (15)
Transcriptomics
Genomics
Proteomics
Computational Biology
Metabolomics
And 10 more
About
I am a dedicated Scientist-I at Garuda Therapeutics, where I specialize in computational biology and genomics within the R&D department. My work primarily revolves around developing and optimizing pipelines for variant calling using Strelka2 and GATK4 with Whole Genome Sequencing (WGS) to identify oncogenes in human induced pluripotent stem cells (iPSCs). This involves extensive work in the qualification and validation of these pipelines for regulatory filings, as well as leveraging databases such as ClinVar, COSMIC, and DepMap to craft targeted oncogenes panels for deep sequencing. I also apply Next-Generation Sequencing (NGS) for downstream sequencing to validate CRISPR knockouts, including the identification and validation of CRISPR off-targets using techniques like rhAMPseq and Induce-seq. Additionally, my expertise extends to single-cell sequencing analysis and understanding structural variants with Optical Genome Mapping (Bionano). Prior to joining Garuda Therapeutics, I completed a postdoctoral fellowship in computational biology at Pennsylvania State University, where I honed my skills in identifying climate-adaptive variants and conducted Genome-Wide Association Studies (GWAS) to uncover resistance genes against parasites and other stressors. My academic journey began at the University of Vermont, where I explored abiotic stress resistance genes using transcriptomics and developed a robust understanding of RNA-seq data analysis, from assembly to gene annotation. My work is driven by a passion for leveraging computational and genomics tools to address pressing challenges in biology and healthcare, combining my rigorous academic training with a practical, solution-oriented approach to research and development.

See Full Profile

Shariq Usmani, PhD

Boston, Massachusetts, United States of America
15 Years Experience
Massachusetts General Hospital, Harvard Medical School
Education

University of Konstanz

PhD, Molecular and Cell Biology / May, 2011

Konstanz

Harvard University

Postdoctoral fellow, Virology/Immunology / 2019

Cambridge, Massachusetts, United States of America
Experience

Cabaletta Bio

Scientific Director / 2024Present

I lead a research team in the preclinical R&D organization at Cabaletta bio. I directly manage a talented group of Senior Scientists, Scientists and Research Associates to spearhead and drive innovation in cell therapies and biologics in autoimmune disease indications.

Sana Biotechnology

Principal Scientist / 20222023

As a team lead, I led efforts to establish in vivo genome editing platform, vector design/engineering and optimization, with a broader goal to develop innovative and effective genomic medicine for unmet medical needs.

Zohdan Bio

Consultant / 2024Present

Providing strategic support for all aspects of preclinical, R&D programs in gene therapy, genome editing and virology and immunology space.

Most Relevant Research Expertise
Immunology and Allergy
Other Research Expertise (10)
Microbiology
Virology
Immunology
Molecular Biology
Genetics
And 5 more
About
Dr. Shariq Usmani is scientific director at Cabaletta bio, a leader in cell therapy for autoimmune diseases (https://www.cabalettabio.com). He leads a research team in preclinical R&D organization at Cabaletta bio. He directly manage a talented group of Senior Scientists, Scientists and Research Associates to spearhead and drive innovation in cell therapies and biologics in autoimmune disease indications. <br> He is also serves as consultant at Zohdan Bio, where he provides strategic support for preclinical R&D programs focused on gene therapy, genome editing, and virology. With a deep foundation in oncology and biologics, Dr. Usmani has led groundbreaking work in both academia and industry, including his tenures at Sana Biotechnology, Harvard Medical School and Massachusetts General Hospital. He's led and spearheaded the development of innovative in vivo genome editing platforms, optimized viral vectors, and engineered cutting-edge reporter assays.

See Full Profile

Dr. David Siderovski, Ph.D.

Fort Worth
25 Years Experience
Professor of Computational Pharmacology; Chair of HSC SBS Dept. of Pharmacology & Neuroscience
Education

University of Toronto

Ph.D., Medical Biophysics / November, 1997

Toronto, Ontario, Canada
Experience

University of North Carolina at Chapel Hill

Professor / January, 1999June, 2012

West Virginia University School of Medicine

E.J. Van Liere Endowed Medicine Professor and Chairman / July, 2012February, 2020

Chair of the Dept. of Physiology and Pharmacology

University of North Texas Health Science Center

Professor & Chair / March, 2020Present

Most Relevant Research Expertise
Immunology and Allergy
Other Research Expertise (26)
Regulator of G protein Signaling (RGS) proteins
Pharmacology
Molecular Biology
Cellular and Molecular Neuroscience
Molecular Medicine
And 21 more
About
Dr. David Siderovski is a renowned scientist and academic, with a career spanning over two decades. He received his Ph.D. in Medical Biophysics from the University of Toronto in 1997, where he specialized in signal transduction and cellular signaling pathways. After completing his doctorate, Dr. Siderovski held various faculty positions at prestigious universities, including the University of North Carolina at Chapel Hill, West Virginia University School of Medicine, and the University of North Texas Health Science Center. At these institutions, Dr. Siderovski has made significant contributions to the field of pharmacology through his research on G protein-coupled receptors (GPCRs) and RGS proteins, which are key regulators of GPCR cellular signaling. His work has helped to advance the understanding of RGS proteins and their roles in various diseases, including cancer, cardiovascular disorders, and neurological disorders. In addition to his research, Dr. Siderovski is also a dedicated educator and mentor. He has taught and mentored numerous undergraduate, graduate, and medical students, and has served as a mentor for postdoctoral fellows and junior faculty members. He is known for his passion and enthusiasm for science and his ability to inspire and guide the next generation of scientists. Dr. Siderovski has received numerous awards and honors for his contributions to the scientific community. He was the recipient of the Abel Award in 2004 from the American Society of Pharmacology & Experimental Therapeutics for his pioneering discoveries of the RGS proteins and the GoLoco motif. He has also served on editorial boards of several scientific journals (including a decade at *J.Biol.Chem.*) and has been a member of various scientific committees, NIH study section panels, and pharma/biotech advisory boards, including for Inspire, Wyeth, and BellBrook Labs. Overall, Dr. David Siderovski is a highly accomplished and respected scientist and educator, whose research has had a significant impact on the field of pharmacology. His dedication and passion for science continue to inspire and influence the next generation of researchers in this field.

See Full Profile

Garrett A. Perchetti, Research Scientist - Virology

New York
9 Years Experience
Research Scientist and MD Candidate in virology with publications on infectious diseases, laboratory medicine, viral genetics, and clinical medicine
Education

University of Washington

BS, BA, Microbiology; Art History

Seattle, Washington, United States of America

Ross University School of Medicine

MD, Infectious Diseases / April, 2025 (anticipated)

Bridgetown

Harvard University

SSP, Psychology

Cambridge, Massachusetts, United States of America
Experience

University of Washington

Research Scientist / 2015Present

Most Relevant Research Expertise
Immunology and Allergy
Other Research Expertise (15)
Virology
Microbiology
Infectious Diseases
SARS-CoV-2
COVID-19
And 10 more
About
Garrett A. Perchetti is a highly accomplished research scientist in the field of virology. He received a Bachelor of Science in Microbiology and a Bachelor of Arts in Art History from the University of Washington. His interest in both science and the arts led him to pursue a career in virology, where he could combine his passion for understanding the natural world with his creative thinking skills. After completing his undergraduate studies, Garrett continued his education by earning a Medical Degree from Ross University School of Medicine in 2025. During his time in medical school, he developed a keen interest in virology and infectious diseases, which ultimately led him to specialize in this field. Garrett's educational background is complemented by his extensive experience as a research scientist. He has worked at the University of Washington School of Medicine, where he has conducted groundbreaking research on various types of viruses. His work has been published in numerous scientific journals, and he has presented his findings at international conferences. Garrett's contributions to the field of virology have been widely recognized, and he has received several awards and accolades for his work. He is known for his meticulous attention to detail, innovative thinking, and ability to collaborate effectively with other researchers. In his free time, Garrett enjoys painting, hiking, and traveling. He is also passionate about raising awareness about the importance of vaccinations and promoting public health initiatives. With his exceptional education and extensive experience, Garrett A. Perchetti is a valuable asset to the field of virology and will continue to make significant contributions in the future.

See Full Profile

Dr. Justin Whalley, Ph.D

North Chicago, Illinois, United States of America
9 Years Experience
Assistant Professor of Bioinformatics, with experience in finding the quintessential features in large, multi-layered 'omic datasets.
Education

Université d'Évry Val-d'Essonne

Ph.D., Bioinformatics / May, 2015

Évry

University of Bristol

M.Sci., Mathematics / June, 2008

Bristol
Experience

University of Oxford

Senior Bioinformatician / 20172022

Rosalind Franklin University of Medicine and Science Chicago Medical School

Assistant Professor of Bioinformatics / 2023Present

CNAG

Postdoctoral Researcher / 20142017

Most Relevant Research Expertise
Immunology and Allergy
Other Research Expertise (19)
Genomics
Bioinformatics
Immunity
Tensor decomposition
Cancer
And 14 more
About
Dr. Justin P. Whalley was educated in the UK (M.Sci. Mathematics, University of Bristol) and France (Ph.D. Bioinformatics, University of Évry). He moved to Spain to work as a postdoc at the National Center for Genomic Analysis (CNAG). During his time there, he ran the Quality Control working group for the Pan-Cancer Analysis of Whole Genomes project to assess the data coming in and reduce batch effects. This involved collaboration with researchers from the Broad Institute of MIT and Harvard, the German Cancer Research Center and the Wellcome Sanger Institute in the UK. He returned to the UK to work as a [Senior Bioinformatician at the University of Oxford](https://www.well.ox.ac.uk/people/jpw/). His time there coincided with the global pandemic and he was deeply involved in the COvid-19 Multi-omics Blood ATlas (COMBAT) consortium as the lead for the Integration (Tensor) working group. Dr. Whalley became a member of the [faculty of the Chicago Medical School at Rosalind Franklin University of Medicine and Science](https://www.rosalindfranklin.edu/academics/faculty/justin-p-whalley/) in January 2023.

See Full Profile

Rosani Matoso Silva, Ph.D.

11 Years Experience
Fulbrigther Humphrey Fellow 2023-2024 from Brazil
Education

Universidade Federal da Bahia

Doutora, Zootecnista / September, 2013

Salvador

Universidade Federal Rural do Rio de Janeiro

Mestrado, Zootecnia / October, 2009

Seropédica

Universidade Federal Rural do Rio de Janeiro

Graduação, Zootecnia / September, 2007

Seropédica
Experience

Instituto

Diretora-presidente / March, 2020Present

Universidade Federal do Recôncavo da Bahia

Pesquisadora / February, 2014December, 2017

Instituto Federal de Educação, Ciência e Tecnologia Baiano

Professora / February, 2013August, 2013

Most Relevant Research Expertise
Immunology and Allergy
Other Research Expertise (8)
Zootecnia
Food Animals
Animal Science and Zoology
Safety, Risk, Reliability and Quality
Food Science
And 3 more
About
Rosani Matoso Silva is a scientific researcher and activist committed to advancing diversity and black and indigenous leadership in the fields of science and technology (S&T). Her passion and dedication to these causes led her to establish the Mancala Institute, where she serves as the director of research, spearheading innovative projects aimed at developing technological solutions to address social and racial disparities across Brazil. Rosani’s research is deeply influenced by her belief in the need for innovative methods to effectively monitor food insecurity, a critical issue affecting countless vulnerable communities. Rosani was selected for the prestigious Humphrey Fellowship program for 2023-2024, an opportunity that reflects her exceptional commitment and leadership potential. During the program, she seeks to enhance her leadership development, networking, and negotiation skills. Her goal is to build a supportive network with American organizations focused on achieving food security and sovereignty for vulnerable communities, thus expanding the impact of her work and contributing to the creation of a more just and inclusive future. Rosani Matoso Silva is a driving force in the fight for inclusion and social justice in the fields of science and technology, with an unwavering dedication to creating a world where diversity is not only recognized but valued and promoted.

See Full Profile

Example Immunology and Allergy projects

How can companies collaborate more effectively with researchers, experts, and thought leaders to make progress on Immunology and Allergy?

Development of Allergy Treatment

An Immunology and Allergy expert can collaborate with a pharmaceutical company to develop a new and effective treatment for allergies. This collaboration can involve conducting clinical trials, identifying novel therapeutic targets, and optimizing drug delivery methods.

Research on Autoimmune Diseases

Companies in the healthcare industry can collaborate with Immunology and Allergy researchers to study autoimmune diseases. This research can lead to the development of targeted therapies and personalized medicine approaches for patients with autoimmune disorders.

Vaccine Development

Immunology and Allergy experts can contribute to the development of vaccines for various diseases. Their knowledge of the immune system and allergens can help in designing effective vaccines and understanding immune responses to vaccination.

Diagnostic Tools for Allergies

Collaborating with Immunology and Allergy researchers can result in the development of advanced diagnostic tools for allergies. These tools can aid in accurate diagnosis, allergen identification, and personalized treatment plans for patients.

Drug Discovery and Testing

Pharmaceutical companies can collaborate with Immunology and Allergy experts to discover and test new drugs. These experts can provide valuable insights into the immune system's role in diseases and help in identifying potential drug targets.